There's a lot of people who are under the impression that if you are not diabetic and you're using these Medications that you you're selfishly taking a drug away from a diabetic and I would love to hear your take on that McCall McPhereson: Yeah, you know, I think the majority of people who are on these medications for weight [00:36:00] loss, either from, you know, a BMI too high, prediabetes, you know, obesity or overweight, but with a complication of that, you know, of being overweight
Mertz A, Nguyen NA, Katsanos KH, Kwok RM
Collagen density increases, fine lines soften, skin thickness measurably increases
Rated 5 out of 5 Monica C
If finalized, this closes the last major legal pathway for large-scale compounding
Morgan Stanley Research expects that the global market for treatments of type-2 diabetes and obesity could reach $190 billion by 2035, $40 billion more than previously estimated